483
Astellas Pharma Inc.Astellas Pharma Inc. – FDA 483, Oct 27, 2023
Record Details
An FDA inspection of Astellas Pharma Inc. in Yaizu, Shizuoka, Japan, a drug manufacturer, revealed significant deficiencies in their complaint handling system. Specifically, market complaint records lacked scientifically sound justification for root causes, and investigations failed to include essential reviews such as batch, analytical data, and retain sample trending.
View Company Profile
ID · b94c8cff-f872-4329-959e-7bc41db048a4
Other documents for Astellas Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.